1. The U.S. District Court for the District of Columbia has denied a request from Norwich Pharmaceuticals that would require the FDA to grant immediate final approval of its new drug application for its gastrointestinal medication Xifaxan. The company is in the midst of a legal battle with Bausch Health Cos. and its GI business, Salix Pharmaceuticals, over patents for the drug.
2. Omar Massoud, MD, PhD, a former Cleveland Clinic gastroenterologist, pleaded not guilty by reason of insanity to 18 gross sexual imposition and six unlawful restraint charges.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
